摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-amino-3-(3-isopropoxy-phenyl)-3H-quinazolin-4-one | 189937-65-3

中文名称
——
中文别名
——
英文名称
2-amino-3-(3-isopropoxy-phenyl)-3H-quinazolin-4-one
英文别名
4(3H)-Quinazolinone, 2-amino-3-[3-(1-methylethoxy)phenyl]-;2-amino-3-(3-propan-2-yloxyphenyl)quinazolin-4-one
2-amino-3-(3-isopropoxy-phenyl)-3H-quinazolin-4-one化学式
CAS
189937-65-3
化学式
C17H17N3O2
mdl
——
分子量
295.341
InChiKey
CWQXWGZOKWRTTD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    67.9
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-溴异氰酸苯酯2-amino-3-(3-isopropoxy-phenyl)-3H-quinazolin-4-one 在 sodium hydride 作用下, 生成 1-(4-Bromo-phenyl)-3-[3-(3-isopropoxy-phenyl)-4-oxo-3,4-dihydro-quinazolin-2-yl]-urea
    参考文献:
    名称:
    Design and synthesis of novel nonpeptide CCK-B receptor antagonists
    摘要:
    A novel hybrid series of nonpeptide CCK-B receptor antagonists has been designed from two known series derived from asperlicin. An efficient synthesis of 2-aminoquinazolinone, an intermediate for the synthesis of a targeted analog, has been developed. (C) 1997 Elsevier Science Ltd.
    DOI:
    10.1016/s0960-894x(97)00108-x
  • 作为产物:
    描述:
    3-氨基苯异丙醚 氢气溶剂黄146三乙胺 作用下, 以 四氢呋喃甲醇乙醇 为溶剂, 25.0~50.0 ℃ 、101.33 kPa 条件下, 反应 106.0h, 生成 2-amino-3-(3-isopropoxy-phenyl)-3H-quinazolin-4-one
    参考文献:
    名称:
    Novel Nonpeptide CCK-B Antagonists:  Design and Development of Quinazolinone Derivatives as Potent, Selective, and Orally Active CCK-B Antagonists
    摘要:
    We have designed a novel series of CCK-B receptor antagonists by combining key pharmacophores, an arylurea moiety of 1 and a quinazolinone ring of 3, from two known series. Our earlier studies showed that compounds with methylene linkers in our "target" produced moderate binding affinity and selectivity for CCK-B receptors, whereas its higher and lower homologues resulted in loss of affinity. Introduction of -NH- as a linker dramatically enhanced binding affinity and selectivity for CCK-B receptors, thus providing several compounds with single-digit nanomolar binding affinity and excellent selectivity. Analogous to the earlier studies of the series of quinazolinone derivatives 3, we also found 3-isopropoxyphenyl as a preferred substitution on the N-3 quinazolinone. Electron-withdrawing substitutions on the urea terminal phenyl ring enhanced the CCK-B potency. Representative compounds of this series were tested in the functional assay and showed pure antagonist profiles. Compounds 51 and 61 were orally active in the elevated rat X-maze test. These compounds were also evaluated for their pharmacokinetic profile. The absolute oral bioavailability of compound 61 was 22% in rats.
    DOI:
    10.1021/jm970373j
点击查看最新优质反应信息

文献信息

  • Quinazolinone derivatives as cholyecystokinin (CCK) ligands
    申请人:Warner-Lambert Company
    公开号:US05756502A1
    公开(公告)日:1998-05-26
    Novel quinazolinone derivatives with good binding affinity for the CCK-A and CCK-B receptors, pharmaceutical compositions containing them, methods of using them and a novel process for their preparation are taught. The compounds are useful agents to suppress appetite, reduce gastric acid secretion, and the like.
    本发明涉及一种新型喹唑啉衍生物,具有良好的CCK-A和CCK-B受体结合亲和力,包含它们的制药组合物,使用它们的方法以及一种新型的制备方法。这些化合物是有用的制剂,可以抑制食欲,减少胃酸分泌等。
  • Quinazolinone derivatives as cholecystokinin (CCK) ligands
    申请人:Warner-Lambert Company
    公开号:US05869665A1
    公开(公告)日:1999-02-09
    Novel quinazolinone derivatives with good binding affinity for the CCK-A and CCK-B receptors, pharmaceutical compositions containing them, methods of using them and a novel process for their preparation are taught. The compounds are useful agents to suppress appetite, reduce gastric acid secretion, and the like.
    本发明涉及新型喹唑啉衍生物,其对CCK-A和CCK-B受体具有良好的结合亲和力,以及含有它们的制药组合物、使用它们的方法和一种新型制备它们的方法。这些化合物是有用的药剂,用于抑制食欲、减少胃酸分泌等。
  • Design and synthesis of novel nonpeptide CCK-B receptor antagonists
    作者:J.K. Padia、H. Chilvers、P. Daum、R. Pinnock、N. Suman-Chauhan、L. webdale、B.K. Trivedi
    DOI:10.1016/s0960-894x(97)00108-x
    日期:1997.1
    A novel hybrid series of nonpeptide CCK-B receptor antagonists has been designed from two known series derived from asperlicin. An efficient synthesis of 2-aminoquinazolinone, an intermediate for the synthesis of a targeted analog, has been developed. (C) 1997 Elsevier Science Ltd.
  • US5756502A
    申请人:——
    公开号:US5756502A
    公开(公告)日:1998-05-26
  • US5869665A
    申请人:——
    公开号:US5869665A
    公开(公告)日:1999-02-09
查看更多